Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stern

Showing results (1201-1210 of 1,268) with videos related to

Pageof 127
Sort By:
The American Journal of Pathology|September 28, 2006
Posttranslationally modified proteins as mediators of sustained intestinal inflammationMartin Andrassy, John Igwe, Frank Autschbach, et al.
Epilepsy & Behavior : E&B|February 26, 2017
Diagnostic implications of review-of-systems questionnaires to differentiate epileptic seizures from psychogenic seizuresWesley T Kerr, Emily A Janio, Chelsea T Braesch, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Science Signaling|August 27, 2011
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancerSusanna Stinson, Mark R Lackner, Alex T Adai, et al.
Brain Stimulation|July 1, 2021
Safety of focused ultrasound neuromodulation in humans with temporal lobe epilepsyJohn M Stern, Norman M Spivak, Sergio A Becerra, et al.
Diabetes|November 28, 2001
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaBA Bierhaus, S Schiekofer, M Schwaninger, et al.
Science Signaling|June 16, 2011
TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancerSusanna Stinson, Mark R Lackner, Alex T Adai, et al.
Oncogene|February 29, 2012
Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutationsW Yuan, E Stawiski, V Janakiraman, et al.
Blood|May 3, 2002
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediatedJeffrey T Billheimer, Ira B Dicker, Richard Wynn, et al.
Rheumatology (Oxford, England)|March 29, 2024
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritisHermine I Brunner, Nicolino Ruperto, Athimalaipet V Ramanan, et al.
Pageof 127

Showing results (1201-1210 of 1,268) with videos related to

Sort By:
Pageof 127
The American Journal of Pathology|September 28, 2006
Posttranslationally modified proteins as mediators of sustained intestinal inflammationMartin Andrassy, John Igwe, Frank Autschbach, et al.
Epilepsy & Behavior : E&B|February 26, 2017
Diagnostic implications of review-of-systems questionnaires to differentiate epileptic seizures from psychogenic seizuresWesley T Kerr, Emily A Janio, Chelsea T Braesch, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Science Signaling|August 27, 2011
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancerSusanna Stinson, Mark R Lackner, Alex T Adai, et al.
Brain Stimulation|July 1, 2021
Safety of focused ultrasound neuromodulation in humans with temporal lobe epilepsyJohn M Stern, Norman M Spivak, Sergio A Becerra, et al.
Diabetes|November 28, 2001
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaBA Bierhaus, S Schiekofer, M Schwaninger, et al.
Science Signaling|June 16, 2011
TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancerSusanna Stinson, Mark R Lackner, Alex T Adai, et al.
Oncogene|February 29, 2012
Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutationsW Yuan, E Stawiski, V Janakiraman, et al.
Blood|May 3, 2002
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediatedJeffrey T Billheimer, Ira B Dicker, Richard Wynn, et al.
Rheumatology (Oxford, England)|March 29, 2024
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritisHermine I Brunner, Nicolino Ruperto, Athimalaipet V Ramanan, et al.
Pageof 127